Small Molecules
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
57
NCT04901078
A Phase 1 Study Investigating the Safety, Tolerability and Pharmacokinetics of KNX100 in Healthy Volunteers
Phase: Phase 1
Role: Lead Sponsor
Start: Apr 7, 2022
Completion: Sep 30, 2023
Loading map...